VolitionRX Ltd

-0.01 (-0.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)119.89M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.42 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$1.79
50-Day MA$2.01
200-Day MA$1.98
See more pivots

VolitionRX Ltd Stock, ASE:VNRX

1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014
United States of America
Phone: +1.646.650.1351
Number of Employees: 104


VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.